Jeffrey Karp is a venture partner at Catalio Capital Management and professor of medicine at Harvard Medical School. His work in drug delivery, medical devices and regenerative medicine led him to co-found companies including Frequency Therapeutics, Gecko Biomedical, Alivio Therapeutics and AltrixBio.
Jeffrey Karp is a venture partner at Catalio Capital Management and professor of medicine at Harvard Medical School. His work in drug delivery, medical devices and regenerative medicine led him to co-found companies including Frequency Therapeutics, Gecko Biomedical, Alivio Therapeutics and AltrixBio.
Career
Jeffrey Karp studied at McGill University (BEng) and University of Toronto (PhD).
Venture Partner at Catalio Capital Management until PresentHMProfessor of Medicine at Harvard Medical School until Present